| 000 | 01710 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516064113.0 | ||
| 264 | 0 | _c20120625 | |
| 008 | 201206s 0 0 chi d | ||
| 022 | _a0253-3758 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Xiao-Fang | |
| 245 | 0 | 0 |
_a[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention]. _h[electronic resource] |
| 260 |
_bZhonghua xin xue guan bing za zhi _cJul 2011 |
||
| 300 |
_a617-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aCoronary Disease _xdiagnosis |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C19 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 700 | 1 | _aHe, Chen | |
| 700 | 1 | _aYuan, Jin-Qing | |
| 700 | 1 | _aMeng, Xian-Min | |
| 700 | 1 | _aYang, Yue-Jin | |
| 700 | 1 | _aQin, Xue-Wen | |
| 700 | 1 | _aQiao, Shu-Bin | |
| 700 | 1 | _aLiu, Hai-Bo | |
| 700 | 1 | _aWu, Yong-Jian | |
| 700 | 1 | _aYao, Min | |
| 700 | 1 | _aChen, Jue | |
| 700 | 1 | _aYou, Shi-Jie | |
| 700 | 1 | _aWu, Yuan | |
| 700 | 1 | _aLi, Jian-Jun | |
| 700 | 1 | _aDai, Jun | |
| 700 | 1 | _aChen, Ji-Lin | |
| 700 | 1 | _aGao, Run-Lin | |
| 700 | 1 | _aChen, Zai-Jia | |
| 773 | 0 |
_tZhonghua xin xue guan bing za zhi _gvol. 39 _gno. 7 _gp. 617-20 |
|
| 999 |
_c21316173 _d21316173 |
||